These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1666685)

  • 21. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
    Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
    J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neurotensin, dopamine and mode of action of neuroleptics].
    Tassin JP
    Encephale; 1989; 15(5):465-70. PubMed ID: 2574102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of acute and subchronic administration of typical and atypical antipsychotic drugs on the neurotensin system of the rat brain.
    Kinkead B; Shahid S; Owens MJ; Nemeroff CB
    J Pharmacol Exp Ther; 2000 Oct; 295(1):67-73. PubMed ID: 10991962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurotensin: dual roles in psychostimulant and antipsychotic drug responses.
    Dobner PR; Deutch AY; Fadel J
    Life Sci; 2003 Jun; 73(6):801-11. PubMed ID: 12801600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions between neurotensin and dopamine in the brain: an overview.
    Quirion R
    Peptides; 1983; 4(5):609-15. PubMed ID: 6318198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic, but not acute, dosing of antipsychotic drugs alters neurotensin binding in rat brain regions.
    Holtom PE; Needham PL; Bennett GW; Aspley S
    Br J Pharmacol; 2000 Nov; 131(5):990-6. PubMed ID: 11053221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotensin speeds inhibition of dopamine neurons through temporal modulation of GABA
    Tschumi CW; Beckstead MJ
    Neuropharmacology; 2018 Mar; 131():414-423. PubMed ID: 29307543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous neurotensin antagonizes methamphetamine-enhanced dopaminergic activity.
    Wagstaff JD; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1994 Dec; 665(2):237-44. PubMed ID: 7895059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.
    Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intramembrane interactions between neurotensin receptors and dopamine D2 receptors as a major mechanism for the neuroleptic-like action of neurotensin.
    Fuxe K; Von Euler G; Agnati LF; Merlo Pich E; O'Connor WT; Tanganelli S; Li XM; Tinner B; Cintra A; Carani C
    Ann N Y Acad Sci; 1992; 668():186-204. PubMed ID: 1361113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The electrophysiological effects of neurotensin on spontaneously active neurons in the nucleus accumbens: an in vivo study.
    Stowe ZN; Landry JC; Tang Z; Owens MJ; Kinkead B; Nemeroff CB
    Synapse; 2005 Dec; 58(3):165-72. PubMed ID: 16108007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurotensin and neuroendocrine regulation.
    Rostène WH; Alexander MJ
    Front Neuroendocrinol; 1997 Apr; 18(2):115-73. PubMed ID: 9101258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does neurotensin mediate the effects of antipsychotic drugs?
    Kinkead B; Binder EB; Nemeroff CB
    Biol Psychiatry; 1999 Aug; 46(3):340-51. PubMed ID: 10435199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Striatal dopamine receptor plasticity in neurotensin deficient mice.
    Chastain LG; Qu H; Bourke CH; Iuvone PM; Dobner PR; Nemeroff CB; Kinkead B
    Behav Brain Res; 2015 Mar; 280():160-71. PubMed ID: 25449842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
    Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    Gygi SP; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multitasking with neurotensin in the central nervous system.
    Dobner PR
    Cell Mol Life Sci; 2005 Sep; 62(17):1946-63. PubMed ID: 16003489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
    Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
    Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of dopamine in the central effect of neurotensin on intestinal motility in rats.
    Fargeas MJ; Fioramonti J; Bueno L
    Peptides; 1990; 11(6):1169-73. PubMed ID: 2087439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence of somatostatin or neurotensin in lateral septal dopaminergic axon terminals of distinct hypothalamic and midbrain origins: convergence on the somatospiny neurons.
    Jakab RL; Leranth C
    Exp Brain Res; 1993; 92(3):420-30. PubMed ID: 7681010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.